Publications by authors named "A Olveira-Martin"
Article Synopsis
- LPAC (Low Phospholipid-Associated Cholelithiasis) is a rare genetic syndrome that contributes to biliary diseases, and its treatment with bile salts can prevent symptoms and surgeries.
- A study conducted from February 2021 to September 2022 identified 36 LPAC patients, indicating an incidence rate of 2.5% among hospital admissions for biliary causes, with higher rates in younger patients and women.
- Correctly diagnosing LPAC using straightforward criteria could reduce unnecessary hospital admissions and surgeries, particularly in women under 50 experiencing biliary issues.
Article Synopsis
- Transabdominal ultrasound pancreatic 2D-SWE elastography is an emerging technique that requires a standardized protocol for effective use.
- The study involved taking ten measurements of pancreatic elasticity in healthy volunteers, focusing on specific areas and adhering to a strict methodology.
- Results showed high reliability and internal consistency, with a recommendation to take at least five measurements in the most accessible area at a depth of less than 4.8cm for accurate assessment.
Benefits of rilpivirine for liver stiffness in HIV/HCV-coinfected patients.
Enferm Infecc Microbiol Clin (Engl Ed)
February 2024
Background: Rilpivirine (RPV) is an antiretroviral drug characterized by good tolerability and a favorable liver safety profile. Recent research has shown that RPV ameliorates liver fibrosis in animal models of various chronic liver diseases. Our study aimed to analyze the effect of RPV on liver fibrosis by assessing changes in liver stiffness using transient elastography.
View Article and Find Full Text PDFEvidence on the risk of hepatocellular carcinoma (HCC) in patients with stage 3 liver fibrosis (F3) and SVR is scarce and continues to generate uncertainty. Furthermore, the distinction between F3 and F4 disease is complex. Consequently, the latest international guidelines recommend using the same screening protocol for HCC after SVR in both F3 and F4 patients.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates the issue of patients with primary biliary cholangitis (PBC) losing follow-up in the healthcare system, highlighting the negative impacts on their health outcomes.
- An analysis of patient data from four hospitals in Spain revealed that out of 697 patients diagnosed with PBC, 14.3% were classified as lost due to lack of follow-up and treatment.
- The research emphasizes the need to identify and re-engage these lost patients, as many are at risk of advanced liver disease, and leveraging hospital databases can help in retrieving them for necessary monitoring and treatment.